Annual Drug Patent Expirations for JENTADUETO
Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents protecting this drug and two Paragraph IV challenges.
This drug has three hundred and two patent family members in forty-five countries.
The generic ingredient in JENTADUETO is linagliptin; metformin hydrochloride. One supplier is listed for this compound. Additional details are available on the linagliptin; metformin hydrochloride profile page.
Copyright © DrugPatentWatch. Originally published at Patent delisted for Boehringer Ingelheim drug JENTADUETO